AbbVie interferon-free combinations cure most newly treated hepatitis C patients
Adding telaprevir improves acute hepatitis C treatment for HIV-positive men
Simeprevir & sofosbuvir demonstrates good early cure rate with or without ribavirin
Faldaprevir ups interferon response in HIV/HCV co-infection
Simeprevir pushes HCV cure rate above 75% for HIV/HCV co-infection
French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection
Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients
Is a simple sofosbuvir plus ribavirin regimen suitable for difficult-to-treat hepatitis C patients?
Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring
